3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Multiple Myeloma
8
Lymphoma, Follicular
4
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Smoldering Multiple Myeloma
1
Neoplasms
1
Meningeal Carcinomatosis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lymphedema
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Disease Progression
1
Disease
1
Breast Neoplasms
1
Interventions
Pemetrexed
19
Bevacizumab
10
Radiotherapy
8
Spinal Puncture
7
osimertinib
6
Methotrexate
6
Magnetic Resonance Spectroscopy
6
aflutinib
5
Topotecan
5
Specimen Handling
5
Trastuzumab
4
Temozolomide
4
Radiotherapy, Intensity-Modulated
4
Dexamethasone
3
trastuzumab deruxtecan
2
pembrolizumab
2
omburtamab I-131
2
merphos
2
aumolertinib
2
WP 744
2
Vitamin B 12
2
Rituximab
2
Radiation
2
Folic Acid
2
Drug Therapy
2
Cytarabine
2
Cyclophosphamide
2
Capecitabine
2
Busulfan
2
AZD3759
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Meningeal Carcinomatosis
×
Transplantation, Autologous
×
Clear all
NCT00801216
2024-12-10
SCNSL1
IRCCS San Raffaele
Phase 2
Completed
40 enrolled
11 charts